DE60137243D1 - Fettsäure-analogen zur behandlung proliferierender hautstörungen - Google Patents

Fettsäure-analogen zur behandlung proliferierender hautstörungen

Info

Publication number
DE60137243D1
DE60137243D1 DE60137243T DE60137243T DE60137243D1 DE 60137243 D1 DE60137243 D1 DE 60137243D1 DE 60137243 T DE60137243 T DE 60137243T DE 60137243 T DE60137243 T DE 60137243T DE 60137243 D1 DE60137243 D1 DE 60137243D1
Authority
DE
Germany
Prior art keywords
sub
carbon
omega
alkyl
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60137243T
Other languages
English (en)
Inventor
Rolf Berge
Karsten Kristiansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thia Medica AS
Original Assignee
Thia Medica AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica AS filed Critical Thia Medica AS
Application granted granted Critical
Publication of DE60137243D1 publication Critical patent/DE60137243D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
DE60137243T 2000-09-27 2001-09-27 Fettsäure-analogen zur behandlung proliferierender hautstörungen Expired - Lifetime DE60137243D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20004844A NO20004844L (no) 2000-09-27 2000-09-27 Fettsyre analoger for behandling av proliferative hudsykdommer
PCT/NO2001/000393 WO2002026218A2 (en) 2000-09-27 2001-09-27 Fatty acid analogues for the treatment of proliferative skin disorders

Publications (1)

Publication Number Publication Date
DE60137243D1 true DE60137243D1 (de) 2009-02-12

Family

ID=19911618

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60137243T Expired - Lifetime DE60137243D1 (de) 2000-09-27 2001-09-27 Fettsäure-analogen zur behandlung proliferierender hautstörungen

Country Status (17)

Country Link
US (1) US7230029B2 (de)
EP (1) EP1324756B1 (de)
JP (1) JP2004509917A (de)
KR (1) KR100905336B1 (de)
CN (1) CN100579521C (de)
AT (1) ATE418974T1 (de)
AU (2) AU2001294419B2 (de)
BR (1) BR0114137A (de)
CA (1) CA2421729A1 (de)
DE (1) DE60137243D1 (de)
ES (1) ES2317938T3 (de)
HK (1) HK1060692A1 (de)
MX (1) MXPA03002629A (de)
NO (1) NO20004844L (de)
NZ (1) NZ524599A (de)
RU (1) RU2276602C2 (de)
WO (1) WO2002026218A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
EP1515978A1 (de) 2002-06-20 2005-03-23 IC Vec Limited Schwefelhaltige phospholipidderivate
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
DK2275140T3 (en) * 2004-07-19 2018-02-05 Bergen Teknologioverforing As Composition, comprising plant and / or fish oils and non-oxidizable fatty acid units
WO2009006668A1 (en) * 2007-02-05 2009-01-15 Children, Youth And Women's Health Service Modulators of antigen-dependent t cell proliferation
US8602833B2 (en) 2009-08-06 2013-12-10 May Patents Ltd. Puzzle with conductive path
US9597607B2 (en) 2011-08-26 2017-03-21 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US11330714B2 (en) 2011-08-26 2022-05-10 Sphero, Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US9019718B2 (en) 2011-08-26 2015-04-28 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
USD732475S1 (en) 2012-11-19 2015-06-23 Littlebits Electronics Inc. Connector for modular electronic building system
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
EP3522865A4 (de) 2016-10-04 2020-06-17 Mary Kay Inc. Verfahren und zusammensetzungen zur behandlung von striae distensae
WO2020053833A1 (en) * 2018-09-14 2020-03-19 Université de Lausanne Methods for modulating regulatory t cells and inhibiting tumor growth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
DE19516705C2 (de) * 1995-05-06 1997-10-02 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Substanzen
FR2792312B1 (fr) * 1999-04-15 2001-06-08 Oreal Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger

Also Published As

Publication number Publication date
EP1324756B1 (de) 2008-12-31
HK1060692A1 (en) 2004-08-20
KR20030036843A (ko) 2003-05-09
MXPA03002629A (es) 2004-05-24
WO2002026218A2 (en) 2002-04-04
RU2276602C2 (ru) 2006-05-20
KR100905336B1 (ko) 2009-07-01
ATE418974T1 (de) 2009-01-15
CN100579521C (zh) 2010-01-13
BR0114137A (pt) 2003-08-12
CA2421729A1 (en) 2002-04-04
US20040019108A1 (en) 2004-01-29
CN1466453A (zh) 2004-01-07
ES2317938T3 (es) 2009-05-01
US7230029B2 (en) 2007-06-12
NO20004844L (no) 2002-05-10
JP2004509917A (ja) 2004-04-02
AU9441901A (en) 2002-04-08
NZ524599A (en) 2004-11-26
EP1324756A2 (de) 2003-07-09
NO20004844D0 (no) 2000-09-27
WO2002026218A3 (en) 2002-06-13
AU2001294419B2 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
BR9910297A (pt) Novos análogos graxos para o tratamento de diabetes
DE60137243D1 (de) Fettsäure-analogen zur behandlung proliferierender hautstörungen
DE60118198D1 (de) Fettsäure-analoge zur behandlung von krebs
BR0108950A (pt) Novos análogos de ácido graxo
IL145123A0 (en) C16 unsaturated fp-selective prostaglandin analogs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition